Value20202021202220232024TTMSelling/general/admin expenses317.88 M282.66 M451.42 M481.87 M557.87 M527.29 MResearch & development722.34 M771.18 M877.09 M877.39 M804.52 M1.4 BOperating income564.16 M459.71 M536.2 M267.82 M218.08 M679.63 MNon-Operating Income, Total11.1 M40.76 M153.76 M252.27 M42.69 M221.91 MInterest expense, net of interest capitalized59.95 M63.52 M53.25 M22.01 M18.39 M21.77 MNon-Operating Income, excl. Interest Expenses-49.37 M-23.7 M135.53 M197.21 M-18.39 M20.94 MUnusual income/expense517 K936 K-35.02 M33.05 M42.69 M179.21 MPretax income553.07 M418.95 M689.96 M520.1 M260.77 M902.95 MEquity in earnings————0—Taxes1.06 M168 K13.53 M15.88 M25.54 M134.13 MNon-controlling/minority interest——————After tax other income/expense470 K7.62 M9.64 M37 K2.13 M1 MNet income before discontinued operations554.13 M418.78 M703.49 M535.98 M235.24 M983.4 MDiscontinued operations——————Net income554.13 M418.78 M703.49 M535.98 M235.24 M983.4 MDilution adjustment——————Preferred dividends——————Diluted net income available to common stockholders554.13 M418.78 M703.49 M535.98 M252.24 M1 BBasic earnings per share (Basic EPS)——-8.03-5.82.47-2.72Diluted earnings per share (Diluted EPS)7.115.15-8.03-5.82.34-2.95Average basic shares outstanding77.96 M81.26 M87.56 M92.4 M95.08 M390.68 MDiluted shares outstanding77.96 M81.26 M87.56 M92.4 M107.88 M412.1 MEBITDA——————EBIT——————Cost of revenue——————Other cost of goods sold——————Depreciation & amortization (cash flow)26.91 M38.02 M41.86 M44.4 M37.72 M49.72 M
Sarepta Therapeutics Inc
Sarepta Therapeutics, Inc. is a medical research and drug development company with corporate offices and research facilities in Cambridge, Massachusetts, United States. Incorporated in 1980 as AntiVirals, shortly before going public the company changed its name from AntiVirals to AVI BioPharma soon with stock symbol AVII and in July 2012 changed name from AVI BioPharma to Sarepta Therapeutics and SRPT respectively. As of 2023, the company has four approved drugs.